StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 15/3031% above fair value
$520.66−15.79 (-2.94%)

Close on Nov 19, 2026Market cap $131.97BP/E 30.3Yield –

Vertex Pharmaceuticals Other revenues by Quarter

Other revenues (collaborative & royalty revenues, $M) ($M)

Vertex Pharmaceuticals Other revenues: $0M in Q2 2026, down 100.0% from a year earlier. That is the lowest of the 34 quarters on record here.

Latest, Q2 2026
0
Period ended Jun 30, 2026
Change on a year earlier
-100.0%
20.7 in Q2 2025
History
34 quarters
Since Q1 2017
Sources
16
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-08-04) ↗

Reported in Form 10-Q / 10-K Revenue Disaggregation Note.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOther revenues (collaborative & royalty revenues, $M) ($M)Year on yearSource
Q2 2026Jun 30, 20260-100.0%Form 10-Q (filed 2026-08-04) ↗
Q1 2026Mar 31, 20260-100.0%Form 10-Q (filed 2026-05-05) ↗
Q4 2025Dec 31, 20250–Form 10-K (filed 2026-02-13) ↗
Q3 2025Sep 30, 20250–Form 10-Q (filed 2025-11-04) ↗
Q2 2025Jun 30, 202520.7–Form 10-Q (filed 2026-08-04) ↗
Q1 2025Mar 31, 202510–Form 10-Q (filed 2026-05-05) ↗
Q4 2024Dec 31, 20240–Form 10-K (filed 2026-02-13) ↗
Q3 2024Sep 30, 20240–Form 10-Q (filed 2025-11-04) ↗
Q2 2024Jun 30, 20240–Form 10-Q (filed 2025-08-05) ↗
Q1 2024Mar 31, 20240–Form 10-Q (filed 2025-05-06) ↗
Q4 2022Dec 31, 20220–Form 10-K (filed 2024-02-15) ↗
Q3 2022Sep 30, 20220–Form 10-Q (filed 2022-10-28) ↗
Q2 2022Jun 30, 20220–Form 10-Q (filed 2022-08-05) ↗
Q1 2022Mar 31, 20220-100.0%Form 10-Q (filed 2022-05-06) ↗
Q4 2021Dec 31, 20210-100.0%Form 10-K (filed 2024-02-15) ↗
Q3 2021Sep 30, 20210-100.0%Form 10-Q (filed 2022-10-28) ↗

Breakdown

What makes up other revenues

Cite this data

StockData. (2026). Vertex Pharmaceuticals Other revenues ($M), quarterly Q1 2017–Q2 2026 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/rev-collab-royalty

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.

See a number that looks wrong?